Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Shortcomings in the US Pharmaceutical Supply Chain

Shortcomings in the US Pharmaceutical Supply Chain This Viewpoint discusses vulnerabilities in the US drug supply chain given a shift in manufacturing of pharmaceutical ingredients to other countries and calls for a system to identify high-value medications, forecast supplies and shortages, and incentivize domestic production. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Shortcomings in the US Pharmaceutical Supply Chain

Oehler, Richard L.; Gompf, Sandra G.
JAMA , Volume 324 (2) – Jul 14, 2020
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/shortcomings-in-the-us-pharmaceutical-supply-chain-W2rXwaLh4X

References (1)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2020.1634
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint discusses vulnerabilities in the US drug supply chain given a shift in manufacturing of pharmaceutical ingredients to other countries and calls for a system to identify high-value medications, forecast supplies and shortages, and incentivize domestic production.

Journal

JAMA – American Medical Association

Published: Jul 14, 2020

There are no references for this article.